Holly B. Kordasiewicz
EVP, Chief Development Officer · 3 filings · Latest: Jun 12, 2026
IONIS PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IONS | Holly B. Kordasiewicz | EVP, Chief Development Officer | Jun 12, 2026 | Sale | $73.41 | 60,846 | $4.5M | 22,458 | |
IONS | Holly B. Kordasiewicz | EVP, Chief Development Officer | Jun 12, 2026 | Option Exercise | $53.97 | 60,846 | $3.3M | 83,304 | |
IONS | Kordasiewicz Holly B. | — | Jun 12, 2026 | Proposed Sale | $73.41 | 60,846 | $4.5M | — | |
IONS | Holly B. Kordasiewicz | EVP, Chief Development Officer | Jan 16, 2026 | Sale | $75.66 | 4,141 | $313.3K | 14,718 | |
IONS | Holly B. Kordasiewicz | EVP, Chief Development Officer | Jan 15, 2026 | Option Exercise | $0.00 | 11,119 | — | 18,859 | |
IONS | Kordasiewicz Holly B. | — | Jan 16, 2025 | Proposed Sale | $76.19 | 4,141 | $315.5K | — |